James Hakim

3.1k citations
37 papers · 2.5k · 2 hit papers · h-index 21

Impact in

    • HIV/AIDS drug development and treatment
    • Tuberculosis Research and Epidemiology
    • HIV/AIDS Research and Interventions
  • Virology top 5%
    • HIV Research and Treatment

Papers in

    • HIV/AIDS drug development and treatment 26
    • HIV/AIDS Research and Interventions 5
    • Tuberculosis Research and Epidemiology 3
    • Antifungal resistance and susceptibility 1
    • HIV-related health complications and treatments 4

James Hakim

37 papers receiving 2.3k citations

James Hakim's Hit Papers

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis 2021 · 372 citations
3720+5+10Years since publication100200300400

Peers

James Hakim
Comparison fields: 5 of 84
  • Infectious Diseases 1.7k
  • Virology 129
  • Emergency Medicine 141
  • Epidemiology 212
  • Nephrology 65
Replace Jihad Slim with:
Jihad Slim United States
Vania Giacomet Italy
Helen Sambatakou Greece
Giuseppe Vittorio De Socio Italy
Indira Brar United States
Duncan R. Churchill United Kingdom
Ana Guelar Spain
Sabina Herrera Spain
Djordje Jevtović Serbia
Celestino Rey‐Joly Spain
James Hakim relative to Jihad Slim United States Jihad Slim's profile →
Citations per field
00.5×2×3×4.3×
Jihad Slim · 1×
Citations per year

Countries citing papers authored by James Hakim

Since Specialization
Citations

This map shows the geographic impact of James Hakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hakim more than expected).

Fields of papers citing papers by James Hakim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Hakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hakim. The network helps show where James Hakim may publish in the future.

Co-authors

The 25 scholars most cited alongside James Hakim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Hakim Line = papers co-authored together James Hakim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Hit paper breakdown →
2011451
2
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Hit paper breakdown →
2021372
3 2014199
4 2000190
5 2014176
6 2008135
7 2021123
8 2012113
9 202299
10 201571
11 201668
12 201447
13 201737
14 202037
15 201134
16 200733
17 202131
18 201830
19 201525
20 202225

About James Hakim

James Hakim is a scholar working on Infectious Diseases, Emergency Medicine, Virology, Pharmacy and Microbiology, having authored 37 papers that have together received 2.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (5 papers), HIV-related health complications and treatments (4 papers), Infectious Diseases and Tuberculosis (3 papers), Tuberculosis Research and Epidemiology (3 papers), HIV Research and Treatment (2 papers), Antifungal resistance and susceptibility (1 paper) and Clinical Laboratory Practices and Quality Control (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (129 citations), Emergency Medicine (141 citations), Epidemiology (212 citations) and Nephrology (65 citations). James Hakim has collaborated with scholars based in Zimbabwe, United Kingdom and Uganda. Frequent co-authors include Cissy M Kityo, Innocent T. Gangaidzo, Jens Mielke, Robert S. Heyderman, Peter R. Mason, Valerie J. Robertson, Andrew Ddungu Kambugu, Paula Munderi, Charles F. Gilks and Diana M. Gibb. Their work appears in journals such as New England Journal of Medicine, The Lancet HIV, Clinical Infectious Diseases, BMC Infectious Diseases and PLoS Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact